Search

Author/Creator Mielke, Orell

1. 046 Efficacy and safety of intravenous immunoglobulin (IVIG) IGPRO10 in chronic inflammatory demyelinating polyneuropathy (CIDP). Issue 6 (24th May 2018)

Authors:
Sabet, Arman; Mielke, Orell; Schaik, Ivo N van; Leger, Jean-Marc; Bril, Vera; Gloven, Nan van; Hartung, Hans Peter; Lewis, Richard A; Sobue, Gen; Lawo, John-Philip; Durn, Billie L; Cornblath, David R; Bleecker, Jan LDe; Sommer, Claudia; Robberecht, Wim; Saarela, Mika; Kamienowski, Jerzy; Stelmasi...
Journal:
Journal of neurology, neurosurgery and psychiatry
Issue:
Volume 89:Issue 6(2018)
Page Start:
A19
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 17. Benefit-Risk Profile of Intravenous Immunoglobulin (IVIG) and Subcutaneous Immunoglobulin (SCIG) in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): The PATH study. Issue 3 (March 2020)

Authors:
Shebl, Amgad; Durn, Billie L.; Bril, Vera; Merkies, Ingemar S.J.; Geloven, Nan; Hartung, Hans-Peter; Lewis, Richard A.; Sobue, Gen; Lawo, John-Philip; Cornblath, David R.; Mielke, Orell; van Schaik, Ivo N.
Journal:
Clinical neurophysiology
Issue:
Volume 131:Issue 3(2020:Mar.)
Page Start:
e7
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. 18. Secondary endpoints (PATH extension study): Long-term outcomes of subcutaneous immunoglobulin IgPro20 in CIDP maintenance treatment. Issue 3 (March 2020)

Authors:
van Schaik, Ivo N.; Mielke, Orell; Bril, Vera; Hartung, Hans-Peter; Lewis, Richard A.; Sobue, Gen; Lawo, John-Philip; Praus, Michaela; Durn, Billie L.; Cornblath, David R.; J. Merkies, Ingemar S.
Journal:
Clinical neurophysiology
Issue:
Volume 131:Issue 3(2020:Mar.)
Page Start:
e8
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. 19. Pharmacokinetic modelling and simulation of flexible dosing regimens of subcutaneous immunoglobulin (IgPro20) in CIDP patients. Issue 3 (March 2020)

Authors:
Ma, Xuewen; Lewis, Richard A.; Cornblath, David R.; Yuraszeck, Theresa; Mielke, Orell; Bril, Vera; Hartung, Hans-Peter; Sobue, Gen; Lawo, John-Philip; Durn, Billie L.; J. Merkies, Ingemar S.; van Schaik, Ivo N.; Tortoricci, Michael A.
Journal:
Clinical neurophysiology
Issue:
Volume 131:Issue 3(2020:Mar.)
Page Start:
e8
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. 21. Exposure-response of serum IgG levels and INCAT scores in CIDP patients receiving subcutaneous immunoglobulin (IgPro20). Issue 3 (March 2020)

Authors:
Yuraszeck, Theresa; Lewis, Richard A.; Cornblath, David R.; Ma, Xuewen; Mielke, Orell; Bril, Vera; Hartung, Hans-Peter; Sobue, Gen; Lawo, John-Philip; Durn, Billie L.; J. Merkies, Ingemar S.; van Schaik, Ivo N.; Tortoricci, Michael A.
Journal:
Clinical neurophysiology
Issue:
Volume 131:Issue 3(2020:Mar.)
Page Start:
e9
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Analysis of relapse by inflammatory Rasch‐built overall disability scale status in the PATH study of subcutaneous immunoglobulin in chronic inflammatory demyelinating polyneuropathy. Issue 2 (15th March 2022)

Authors:
Merkies, Ingemar S. J.; van Schaik, Ivo N.; Bril, Vera; Hartung, Hans‐Peter; Lewis, Richard A.; Sobue, Gen; Lawo, John‐Philip; Mielke, Orell; Cornblath, David R.
Journal:
Journal of the peripheral nervous system
Issue:
Volume 27:Issue 2(2022)
Page Start:
159
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Efficacy and safety of Privigen® in patients with chronic inflammatory demyelinating polyneuropathy: results of a prospective, single‐arm, open‐label Phase III study (the PRIMA study). Issue 2 (19th June 2013)

Authors:
Léger, Jean‐Marc; De Bleecker, Jan L.; Sommer, Claudia; Robberecht, Wim; Saarela, Mika; Kamienowski, Jerzy; Stelmasiak, Zbigniew; Mielke, Orell; Tackenberg, Björn; Shebl, Amgad; Bauhofer, Artur; Zenker, Othmar; Merkies, Ingemar S. J.
Journal:
Journal of the peripheral nervous system
Issue:
Volume 18:Issue 2(2013)
Page Start:
130
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Electrophysiological testing in chronic inflammatory demyelinating polyneuropathy patients treated with subcutaneous immunoglobulin: The Polyneuropathy And Treatment with Hizentra (PATH) study. Issue 1 (January 2021)

Authors:
Bril, Vera; Hartung, Hans-Peter; Lawo, John-Philip; Durn, Billie L.; Mielke, Orell
Journal:
Clinical neurophysiology
Issue:
Volume 132:Issue 1(2021)
Page Start:
226
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Hemolysis related to intravenous immunoglobulins is dependent on the presence of anti‐blood group A and B antibodies and individual susceptibility. Issue 11 (25th August 2017)

Authors:
Mielke, Orell; Fontana, Stefano; Goranova‐Marinova, Vesselina; Shebl, Amgad; Spycher, Martin O.; Wymann, Sandra; Durn, Billie L.; Lawo, John P.; Hubsch, Alphonse; Salama, Abdulgabar
Journal:
Transfusion
Issue:
Volume 57:Issue 11(2017)
Page Start:
2629
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗